This medicine is an impressive collection of firsts: not only is it the first drug approved to treat lupus, a potentially fatal disease in which the immune system attacks healthy tissues, it is also one of the first drugs to come out of genomics, the systematic evaluation of human genetics that was epitomized by the human genome project a decade ago.
FORBES: Human Genome Sciences' Benlysta Approved To Treat Lupus